Georgina Arrambide retweeted
Save the date for the iWiMS NMOSD/MOGAD Webinar on Feb 4 2027.
The focus will be on pregnancy, postpartum period, treatments and placental research.
2:00 PM CET
Link: url.au.m.mimecastprotect.com…
password available at [email protected]
iwims.world/
Unifying MS: that was the motto of #MSTORONTO2026 and it did not disappoint. Great days to establish new collaborations and catch up with friends and colleagues from all over the world. @cemcat_em @IntNatlWiMS @vjokubaitis @Ahmed_Abdelhak_ @JensKuhle and many more.
Georgina Arrambide retweeted
Also present at the @IntNatlWiMS meeting alongside @clmguio with her heartwarming experience in the mentorship program with @MarTintore and our lessons learned co-chairing the Clinical Research Study group with @anazabalza @RebeccaMaguire which has been going strong for 7 years
Georgina Arrambide retweeted
The 2026 @ECTRIMS @MSJ_Research F2 Award (first #MultipleSclerosis paper as first authors published in 2025 on our journals) goes to Sarah Lindberg (runner up Maria Sofia Martire).
Congratulations to all participants and see you next year!
The plenary lecture by @danielsaloreich kicks off #MSToronto2026. Interesting talks about applicability and future of the McDonald criteria, presentations by past and present fellows, BioMS educational sessions and meeting, and inspiring talks at the @IntNatlWiMS reception.
Georgina Arrambide retweeted
Opening ceremony at #MSToronto2026
Are you ready for 3 days of #MultipleSclerosis research, clinical practice and networking?
#MSTORONTO2026 starts with the pre-day focused on AE, NMOSD, MOGAD and paediatric MS, with parallel consortium/network meetings already taking place today. @ECTRIMS @ACTRIMS
Georgina Arrambide retweeted
Excellent review by @SaraMariottoMD & colleagues from #MEDEN group on fluid biomarkers in #MOGAD & #NMOSD
➡️ Particularly nice figure on live vs fixed CBA summarizing data to date for both diseases👇
neurology.org/doi/10.1212/NX…
Georgina Arrambide retweeted
Hoy en @lactrims_org Café conversaremos sobre el rol de las fKLC en el diagnóstico de #EsclerosisMultiple y los beneficios y desafíos de su implemetación en la región! Los esperamos junto a @GeoArrambide @neuronavasms @SOCHEDEM1 @neuroinmunUC
Georgina Arrambide retweeted
Many thanks to Dr. Ruth Geraldes and Dra. Georgina Arrambide (@GeoArrambide) for yesterday's excellent session on the overlapping forms of #MS, #NMOSD and #MOGAD. 🙏
And thank you, as always, to everyone who joined us: without you this wouldn't be possible. Also, a big thanks to our partners for making it happen 🤝
☀️ We'll be back after the summer with more sessions - kicking off on September 28 with Prof. Ari J. Green (UCSF), one of the leading voices in myelin repair, on "Remyelination in MS: what the data really tell us", moderated by Dr. Manuel Comabella (Cemcat, HUVH).
➡️ Register and more information here - bit.ly/CIR2026
#CIR26 #CemcatInternationalRounds #Remyelination
Gràcies a la Dra. María Jesús Arévalo i a la Sra. Cristina Ustrell per la sessió d'ahir sobre comunicació i Esclerosi Múltiple, i a la Sra. Carme Miró Alaix pel seu testimoni.
Gràcies també a la Dra. Ingrid Galán per la moderació, i a tots els participants i partners per fer-ho possible. 🙏
🗓️ La pròxima sessió serà el 23 de setembre, dedicada a Embaràs i Esclerosi Múltiple, amb la Prof. Mar Tintoré i la Dra. Paula Tagliani. Us hi esperem!
#EsclerosiMúltiple #Cemcat #SIEM
Georgina Arrambide retweeted
Vivir con NMOSD impacta la salud física, mental y social. En este webinar de TSF LatAm, especialistas y una paciente comparten estrategias para afrontar sus desafíos, mejorar la calidad de vida y fortalecer las redes de apoyo.
▶️ youtube.com/watch?v=nH8zBSN_…
Georgina Arrambide retweeted
IL-6 receptor blockade was associated with low relapse rates and a favorable safety profile in #MOGAD, performing better than low-dose #IVIG and comparably to higher-dose IVIG regimens.
ja.ma/4yfOIfv
Georgina Arrambide retweeted
🚀¿Cuáles son las principales diferencias clínico-radiológicas del MOGAD en adultos y niños?
Mañana, 15 de julio, comienza la 2ª edición de NMOSD Focus Sessions con una sesión dedicada al diagnóstico del MOGAD en población adulta y pediátrica.
🧠 'Características clínico-radiológicas en el diagnóstico del MOGAD en adultos y niños'
Con la participación de:
🔹 Dr. Álvaro Cobo-Calvo - Neurólogo, Cemcat (Barcelona) @cobo_calvo
🔹 Dra. Thaís Armangué - Neuropediatra, Jefa de la Unidad de Neuroinmunología pediátrica, Hospital Sant Joan de Déu (Barcelona)
Con la moderación de:
🔹 Dra. Georgina Arrambide - Neuróloga, Cemcat (Barcelona) @GeoArrambide
📅 Miércoles, 15 de julio de 2026
🕒 15:00 - 16:00h (CEST)
🌐 Online | Español
📌 ¡Aún puedes inscribirte!
👉 bit.ly/NMOSDFocusSessions202…
#NMOSD #MOGAD #Neuroimmunology #MedicalEducation
Georgina Arrambide retweeted
⏱️ 2 h per començar | Avui a les 17:00 h (CEST) - Comunicació i Esclerosi Múltiple dins del programa Sessions Informatives en EM - bit.ly/SIEM130726
Com afecta l'EM en la manera de comunicar-nos? Quines estratègies i recursos hi ha? Quin és el paper de logopèdia? En què consisteix la rehabilitació en la comunicació?
En parlaran la Dra. María Jesús Arévalo (Neuropsicòloga) i la Sra. Cristina Ustrell (Neurologopeda), amb la moderació de la Dra. Ingrid Galán. Comptarem amb el testimoni d'una pacient, que ens explicarà els beneficis d'aquesta experiència.
➡️ Connecta't a través de l'enllaç: bit.ly/SIEM130726
T'hi esperem!
#SIEM #EsclerosiMúltiple #Cemcat
💬 Trobar les paraules, fer-se entendre o explicar als altres com et sents pot ser més difícil del que sembla i convertir-se en un repte quan convius amb l'Esclerosi Múltiple.
🟢 Nova sessió informativa en Esclerosi Múltiple: 'Comunicació i Esclerosi Múltiple'
🗓 Dilluns, 13 de juliol | 17:00 - 18:00 h (CEST)
💻 Online · Gratuïta
👩⚕️ Amb la participació de la Dra. María Jesús Arévalo (neuropsicòloga i co-coordinadora de la Unitat de Rehabilitació del Cemcat), Cristina Ustrell Garrido (logopeda del Cemcat), i la moderació de la Dra. Ingrid Galán (metge i co-coordinadora de la Unitat de Rehabilitació del Cemcat).
Parlarem dels factors cognitius i comunicatius que poden afectar les persones amb EM i de recursos per afrontar-los en el dia a dia.
➡️ Inscriu-te: bit.ly/SIEM-2026
#EsclerosiMúltiple #SIEM #Cemcat #Comunicació
Georgina Arrambide retweeted
🔔 Quedan 2 horas para la segunda sesión de Casos Clínicos en EM Pediátrica | «Esclerosis Múltiple pediátrica: fenotipos de presentación y sus mímics».
¿Cómo distinguir una EM pediátrica de sus principales mímics? Lo vemos analizando casos clínicos reales.
Con la Dra. Silvia Tenembaum y la Dra. Andrea Savransky, y la moderación de la Dra. Georgina Arrambide.
🗓 Hoy, de 15:30 a 16:30h (CEST). Online y gratuita.
Aún estás a tiempo de registrarte: bit.ly/CCEMP2026
#CCEMPed #EsclerosisMúltiple #NeuropediatríaEM
🧠 ¿Cómo distinguir un primer episodio de Esclerosis Múltiple pediátrica de sus mímics? ¿Qué síndromes clínicos deben hacernos pensar en otros diagnósticos como #MOGAD?
🆕 Segunda sesión - Casos clínicos en EM Pediátrica: Esclerosis Múltiple pediátrica: Fenotipos clínicos de presentación y sus "mímics"
🗓 8 de julio | ⏰ 15:30 - 16:30 h (CEST)
💻 Online | Gratuita
🎙 Con la Dra. Silvia Tenembaum, la Dra. Andrea Savransky (Hospital Nacional de Pediatría Garrahan, Buenos Aires) y la moderación de la Prof. Mar Tintoré.
➡️ Regístrate: bit.ly/CCEMP2026
#CCEMPed #EsclerosisMúltiple #NeuropediatríaEM
Controversy session about cures for neuroinflammatory diseases of the CNS at the @EANeurology annual meeting. Also good for networking with veteran and young colleagues alike, including meeting F2F with my @IntNatlWiMS mentee. @v_tseriotis @irenetrefrenk @ikerelosua and more.
🏆 Just 1 month to go! Have you applied for the 2026 ECTRIMS MSJ "First First Author" Awards yet?
Recognising quality research from Multiple Sclerosis Journal authors who published their first MS full article as first authors in 2025, this award supports early career researchers and helps amplify their important work on the world stage at #MSToronto2026.
📩 𝐅𝐨𝐫 𝐟𝐮𝐥𝐥 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐝𝐞𝐭𝐚𝐢𝐥𝐬: bit.ly/4usFFW1
The MSJ & MSJ ETC Editorial Board will evaluate applications based on:
• Quality of the paper
• Setting of the authors
• Career stage of the applicant
• Number of downloads of manuscript presented
• Interest of manuscript (as scored by referees)
🎖️ 𝐀𝐰𝐚𝐫𝐝𝐬:
• Winner: £500 cash award + 1 year MSJ access
• Runner-up: 1 year MSJ access
• Award ceremony at the hashtag#MSToronto2026 Closing Ceremony
🗓️ 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 𝟐𝟒 𝐉𝐮𝐥𝐲 𝟐𝟎𝟐𝟔, 𝟎𝟎:𝟎𝟎 𝐂𝐄𝐓
@MSJ_Research
#MultipleSclerosis #MSResearch #EarlyCareers #ECTRIMS #MSJ #Neurology #ECTRIMSNextGen
2026 Masterclass on pregnancy in MS and antibody-mediated neurological diseases. Interesting discussions with a multidisciplinary approach including neurologists, ObGyns, paediatricians, and biologists. @paula_tagliani @C_OrejaGuevara @KerstinHellwig @vjokubaitis and many more.
Georgina Arrambide retweeted
Tur et al. introduce Spider-MS, a prognostic model designed to predict how MS will progress in an individual after a first demyelinating attack. Spider-MS has the potential to improve risk stratification and support more personalised treatment decisions. shorturl.at/ts07A
Successful MEDEN meeting in Verona. Project proposals by the working groups and hot topics discussions. And brava @SaraMariottoMD (and team) for handling all issues skillfully, especially the transportation strikes. With @marignierro @RosaCortese5 @EoinFlanagan14 and many more!












































